<?xml version="1.0"?>
<!DOCTYPE TimeML SYSTEM "TimeML.dtd">
<TimeML>
Intuitive Surgical, Inc. (NASDAQ:ISRG) – Stock analysts at  Wedbush issued their Q1 <TIMEX3 tid="t1" type="DATE" value="2017">2017</TIMEX3> EPS estimates for shares of Intuitive Surgical  in a note issued to investors on  <TIMEX3 tid="t2" type="DATE" value="2017-01-25">Wednesday</TIMEX3>. Wedbush analyst Levy. T expects that the firm will earn $3.96 per share for <TIMEX3 tid="t3" type="DATE" value="2017-Q1">the quarter</TIMEX3>. Wedbush <TIMEX3 tid="t4" type="DATE" value="PRESENT_REF">currently</TIMEX3>  has a “Outperform” rating and a $800.00 target price on the stock. Wedbush also issued estimates for Intuitive Surgical’s Q3 2017 earnings at $4.89 EPS and Q4 2017 earnings at $5.69 EPS. 
 
Other analysts also <TIMEX3 tid="t9" type="DATE" value="PAST_REF">recently</TIMEX3> issued research reports about the company. Canaccord Genuity  reaffirmed a “buy” rating on shares of Intuitive Surgical in a research note on <TIMEX3 tid="t10" type="DATE" value="2017-01-25">Wednesday</TIMEX3>. RBC Capital Markets  set a $760.00 price target on Intuitive Surgical and gave the company a “hold” rating in a research report on <TIMEX3 tid="t13" type="DATE" value="2016-10-19">Wednesday, October 19th</TIMEX3>. Evercore ISI cut Intuitive Surgical from a “buy” rating to a “hold” rating and set a $690.00 price target on the stock. in a research report on <TIMEX3 tid="t17" type="DATE" value="2017-01-04">Wednesday, January 4th</TIMEX3>. Royal Bank Of Canada lifted their price target on Intuitive Surgical from $750.00 to $760.00 and gave the company a “sector perform” rating in a research report on <TIMEX3 tid="t21" type="DATE" value="2017-10-19">Wednesday, October 19th</TIMEX3>. Finally, Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $784.00 price target on the stock in a research report on <TIMEX3 tid="t25" type="DATE" value="2017-10-20">Thursday, October 20th</TIMEX3>. One investment analyst  has rated the stock with a sell rating, eight have assigned  a hold rating and twelve have assigned  a buy rating to the company’s stock. Intuitive Surgical presently has a consensus rating of “Buy” and a consensus target price of $731.97. 
 
TRADEMARK VIOLATION NOTICE: “ ” was  posted by sleekmoney and is owned by of sleekmoney. If you are accessing this article on another site, it was illegally copied and republished in violation of United States & international copyright & trademark laws. The original version of this article can be accessed at http://sleekmoney.com/intuitive-surgical-inc-isrg-to-post-q1-<TIMEX3 tid="t28" type="DATE" value="2017">2017</TIMEX3>-earnings-of-3-96-per-share-wedbush-forecasts/<TIMEX3 tid="t27" type="DATE" value="1630-12-2">1630122</TIMEX3>.html. 
 
Intuitive Surgical ( NASDAQ:ISRG ) opened at 691.29 on <TIMEX3 tid="t29" type="DATE" value="2017-01-27">Friday</TIMEX3>. The stock has a market capitalization of $26.82 billion, a P/E ratio of 36.91 and a beta of 0.52. The company’s <TIMEX3 tid="t30" type="DURATION" value="P50D">50-day</TIMEX3> moving average price is $649.43 and its <TIMEX3 tid="t32" type="DURATION" value="P200D">200 day</TIMEX3> moving average price is $673.77. Intuitive Surgical has a <TIMEX3 tid="t33" type="DURATION" value="P52W">52-week</TIMEX3> low of $502.01 and a <TIMEX3 tid="t34" type="DURATION" value="P52W">52-week</TIMEX3> high of $727.25. 
 
  
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on <TIMEX3 tid="t37" type="DATE" value="2017-01-24">Tuesday, January 24th</TIMEX3>. The company reported $6.09 earnings per share for <TIMEX3 tid="t39" type="DATE" value="2017-Q1">the quarter</TIMEX3>, topping the Thomson Reuters’ consensus estimate of $5.99 by $0.10. Intuitive Surgical had a return on equity of 14.24% and a net margin of 27.21%. The firm had revenue of $757 million for <TIMEX3 tid="t40" type="DATE" value="2017-Q1">the quarter</TIMEX3>, compared to the consensus estimate of $739.65 million. During the same period in the prior year, the business posted $5.89 earnings per share. The firm’s revenue for <TIMEX3 tid="t42" type="DATE" value="2017-Q1">the quarter</TIMEX3> was up 11.9% compared to the same quarter <TIMEX3 tid="t41" type="DATE" value="2016">last year</TIMEX3>. 
 
In other news, Director Lonnie M. Smith sold 275 shares of the firm’s stock in a transaction on <TIMEX3 tid="t45" type="DATE" value="2016-11-17">Thursday, November 17th</TIMEX3>. The stock was sold at an average price of $646.50, for a total value of $177,787.50. Following the completion of the sale, the director <TIMEX3 tid="t47" type="DATE" value="PRESENT_REF">now</TIMEX3> owns 235,890 shares of the company’s stock, valued at $152,502,885. The sale was disclosed in a legal filing with the SEC, which is accessible through this link . Also, Director Lonnie M. Smith sold 1,000 shares of the firm’s stock in a transaction on <TIMEX3 tid="t50" type="DATE" value="2016-12-13">Tuesday, December 13th</TIMEX3>. The stock was sold at an average price of $650.00, for a total value of $650,000.00. Following the completion of the sale, the director <TIMEX3 tid="t52" type="DATE" value="PRESENT_REF">now</TIMEX3> directly owns 235,971 shares of the company’s stock, valued at approximately $153,381,150. The disclosure for this sale can be found here . Insiders sold a total of 22,990 shares of company stock worth $15,391,558 <TIMEX3 tid="t55" type="DURATION" value="P90D" mod="MORE_THAN">over the last 90 days</TIMEX3>. Insiders own  3.10% of the company’s stock. 
 
TRADEMARK VIOLATION NOTICE: “Intuitive Surgical, Inc. (ISRG) to Post Q1 2017 Earnings of $3.96 Per Share, Wedbush Forecasts” was  posted by sleekmoney and is owned by of sleekmoney. If you are accessing this article on another site, it was illegally copied and republished in violation of United States & international copyright & trademark laws. The original version of this article can be accessed at http://sleekmoney.com/intuitive-surgical-inc-isrg-to-post-q1-<TIMEX3 tid="t59" type="DATE" value="2017">2017</TIMEX3>-earnings-of-3-96-per-share-wedbush-forecasts/<TIMEX3 tid="t58" type="DATE" value="1630-12-2">1630122</TIMEX3>.html. 
 
Several hedge funds have <TIMEX3 tid="t60" type="DATE" value="PAST_REF">recently</TIMEX3> modified their holdings of the company. Robeco Institutional Asset Management B.V. boosted its stake in shares of  Intuitive Surgical by 6.3% in <TIMEX3 tid="t61" type="DATE" value="2016-Q2">the second quarter</TIMEX3>. Robeco Institutional Asset Management B.V. <TIMEX3 tid="t62" type="DATE" value="PRESENT_REF">now</TIMEX3> owns 35,258 shares of the company’s stock valued at $23,320,000 after buying an additional 2,078 shares during the period.  Tairen Capital Ltd acquired a new stake in shares of  Intuitive Surgical during <TIMEX3 tid="t63" type="DATE" value="2016-Q2">the second quarter</TIMEX3> valued at approximately $7,011,000.  Retirement Systems of Alabama boosted its stake in shares of  Intuitive Surgical by 2.7% in <TIMEX3 tid="t64" type="DATE" value="2016-Q2">the second quarter</TIMEX3>. Retirement Systems of Alabama <TIMEX3 tid="t65" type="DATE" value="PRESENT_REF">now</TIMEX3> owns 19,404 shares of the company’s stock valued at $12,834,000 after buying an additional 508 shares during the period.  Candriam Luxembourg S.C.A. boosted its stake in shares of  Intuitive Surgical by 34.9% in <TIMEX3 tid="t66" type="DATE" value="2016-Q2">the second quarter</TIMEX3>. Candriam Luxembourg S.C.A. <TIMEX3 tid="t67" type="DATE" value="PRESENT_REF">now</TIMEX3> owns 1,203 shares of the company’s stock valued at $796,000 after buying an additional 311 shares during the period.  Finally, American Century Companies Inc. boosted its stake in shares of  Intuitive Surgical by 0.7% in <TIMEX3 tid="t68" type="DATE" value="2016-Q2">the second quarter</TIMEX3>. American Century Companies Inc. <TIMEX3 tid="t69" type="DATE" value="PRESENT_REF">now</TIMEX3> owns 415,307 shares of the company’s stock valued at $274,688,000 after buying an additional 2,854 shares during the period. 91.67% of the stock is owned by institutional investors and hedge funds. 
 
About Intuitive Surgical 
 
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. 
 
 
 
 



 
  

 
 




 
     
</TimeML>
